The European Academy of Allergy and Clinical Immunology has developed a clinical practice guideline that aims to provide evidence-based recommendations for the use of AIT as an adjunct treatment for allergic asthma.
This guideline has been developed by a multi-disciplinary working expert group and applies the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.
The aim of this Guideline is to provide evidence-based clinical recommendations for use of AIT in the treatment of allergic asthma and to identify gaps in knowledge, implementation barriers, unmet needs and future perspectives.
Please access the guidelines below:
EAACI guidelines on Allergen Immunotherapy: House dust mites driven Allergic Asthma
Looking forward hearing from you.
EAACI AIT Asthma Guidelines Chairs
Ioana Agache, Susanne Lau and Marek Jutel